Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
4
×
life sciences
national blog main
national top stories
roche
4
×
boston blog main
boston top stories
fda
boston
deals
drug pricing
europe top stories
genentech
national
new york blog main
new york top stories
san francisco blog main
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
billy dunn
biogen
biopharma
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cancer
cancer immunotherapy
center for medicare and medicaid services
ceo
clinical hold
clinical study
clinical trials
combination
commissioner
What
medicine
4
×
roche
big
billion
fda
recently
therapy
acquire
agreed
approval
approved
atrophy
betting
bio
biopharma
bosley's
bosley’s
bridge
broad
bucks
cas
ceo
confidence
crime
crispr
daily
deal
departure
didn’t
drug
duchenne
editas
evrysdi
exit
foundation
friday
gain
gene
genentech
green
Language
unset
Current search:
roche
×
photo
×
biotech
×
medicine
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine